Company: KEQU
Filing Date: 2025-12-12
Form Type: 10-Q
Source: 0000055529-25-000054
Chunk: 9

Company: KEWAUNEE SCIENTIFIC CORP /DE/
Filing Date: 2025-12-12
Form: 10-Q
Item: Part I, Item 1
Chunk 9
---
Item 1.    Condensed Consolidated Financial Statements

Kewaunee Scientific Corporation

Condensed Consolidated Statements of Operations

(Unaudited)

($ and shares in thousands, except per share amounts)

 Three Months EndedOctober 31,Six Months EndedOctober 31, 2025202420252024Net sales$70,096 $47,764 $141,200 $96,157 Cost of products sold50,376 33,812 100,550 69,717 Gross profit19,720 13,952 40,650 26,440 Operating expenses15,613 9,518 31,733 19,431 Operating profit4,107 4,434 8,917 7,009 Other income (expense), net407 (61)575 266 Interest expense(1,061)(442)(2,119)(914)Profit before income taxes3,453 3,931 7,373 6,361 Income tax expense915 916 1,676 1,108 Net earnings2,538 3,015 5,697 5,253 Less: Net earnings attributable to the non-controlling interest93 7 159 52 Net earnings attributable to Kewaunee Scientific Corporation$2,445 $3,008 $5,538 $5,201 Net earnings per share attributable to Kewaunee Scientific Corporation stockholdersBasic$0.85 $1.05 $1.94 $1.82 Diluted$0.82 $1.01 $1.86 $1.75 Weighted average number of common shares outstandingBasic2,866 2,872 2,859 2,861 Diluted2,990 2,974 2,977 2,971 

See accompanying notes to Condensed Consolidated Financial Statements.

1

Kewaunee Scientific Corporation

Condensed Consolidated Statements of Comprehensive Earnings

(Unaudited)

($ in thousands)

 Three Months EndedOctober 31,Six Months EndedOctober 31, 2025202420252024Net earnings$2,538 $3,015 $5,697 $5,253 Other comprehensive loss, net of tax:Foreign currency translation adjustments(164)(76)(574)(192)Other comprehensive loss(164)(76)(